4,497
Participants
Start Date
January 31, 2010
Study Completion Date
September 30, 2011
Nifedipine (Adalat, BAYA1040)
Previously untreated hypertensive adult patients starting with combination therapy containing nifedipine or insufficiently controlled hypertensive patients receiving nifedipine as an add-on to existing non-CCB containing antihypertensive therapy. The decision of including the patient as well as decision on dosage and duration is taken by the investigator.
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Lead Sponsor
Bayer
INDUSTRY